tolbutamide has been researched along with vasoactive intestinal peptide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brayden, JE; Davies, NW; Huang, Y; Nelson, MT; Quayle, JM; Standen, NB | 1 |
| Dyben, T; Ellison, EC; Howe, BA; Mekhjian, HS; Minton, JP; O'Dorisio, TM; Tuttle, SE; Woltering, EA | 1 |
2 other study(ies) available for tolbutamide and vasoactive intestinal peptide
| Article | Year |
|---|---|
Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle.
Topics: Acetylcholine; Adenosine Triphosphate; Animals; Benzopyrans; Cerebral Arteries; Cromakalim; Diazoxide; Glyburide; Guanidines; Mesenteric Arteries; Muscle, Smooth, Vascular; Pinacidil; Potassium Channels; Pyrroles; Rabbits; Rats; Tolbutamide; Vasoactive Intestinal Peptide; Vasodilator Agents | 1989 |
The response of a non-functional VIP- and somatostatin-containing tumour to tolbutamide in vitro.
Topics: Aged; Duodenal Neoplasms; Female; Humans; In Vitro Techniques; Paraneoplastic Endocrine Syndromes; Somatostatin; Tolbutamide; Vasoactive Intestinal Peptide | 1986 |